ISPE and Gilead Sciences have partnered up for the establishment of an internship program.
According to a Dec. 8, 2020 press release, the International Society for Pharmaceutical Engineering (ISPE) and Gilead Sciences have partnered up for the establishment of an internship program.
The ISPE Foundation Diversity Internship Program is a 12-week course, which will take place in the summer months, offering graduate students and undergraduate students the opportunity of working on high-priority, impactful engineering and facilities projects and workstreams in Gilead’s Corporate Operations organization. Currently, two internship opportunities are available at Gilead: Mechanical engineering with a focus on energy/sustainability; and electrical engineering with a focus on process control/automation.
“It is a privilege to partner with Gilead on the launch of a program that will be truly life changing to the careers of a diverse pool of talented students and future leaders in the pharmaceutical field,” said Antonio Moreira, PhD, ISPE Foundation Board chair, vice provost, Academic Affairs, University of Maryland Baltimore County, in the press release. “The ISPE Foundation Diversity Internship Program interns will be immersed in creative and innovative projects, they will be connected with role models and senior leaders at Gilead, and they will be encouraged to let their imagination go to places they had not thought possible. I can't think of a more inspiring and energizing way to start my role as the ISPE Foundation Chair.”
“Gilead is committed to investing in the next generation of engineers and are pleased to partner with the ISPE Foundation on this program,” added Joydeep Ganguly, senior vice-president of Corporate Operations at Gilead, in the press release. “We believe that diverse teams are inherently strong teams and look forward to the ways these interns will contribute to our highest priority projects.”
Source: ISPE
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.